PHASEBIO PHARMACEUTICALS INC's ticker is PHAS and the CUSIP is 717224109. A total of 52 filers reported holding PHASEBIO PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $50,000 | – | 11,990 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Johnson & Johnson Innovation - JJDC, Inc. | 1,607,044 | $5,319,000 | 2.90% |
| NEA Management Company, LLC | 6,643,704 | $21,991,000 | 1.15% |
| DAFNA Capital Management LLC | 320,542 | $1,061,000 | 0.44% |
| Ghost Tree Capital, LLC | 497,074 | $1,645,000 | 0.44% |
| Rock Springs Capital Management LP | 1,125,000 | $3,724,000 | 0.15% |
| SABBY MANAGEMENT, LLC | 107,577 | $356,000 | 0.15% |
| Platform Technology Partners | 34,750 | $115,000 | 0.10% |
| Quantitative Systematic Strategies LLC | 10,938 | $36,000 | 0.03% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 183,500 | $607,000 | 0.01% |
| Capital Advisory Group Advisory Services, LLC | 2,800 | $9,000 | 0.01% |